Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already
caused 6 million deaths worldwide. While asymptomatic individuals are responsible of many …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection significantly
affects the cardiovascular system, causing vascular damage and thromboembolic events in …

Background Endothelial dysfunction plays a central role in the pathophysiology of COVID-19
and is closely linked to the severity and mortality of the disease. The inflammatory response …

Increase in thrombotic and microvascular complications is emerging to be a key feature of
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …

Purpose Endothelial damage and angiogenesis are fundamental elements of
neovascularisation and fibrosis observed in patients with coronavirus disease 2019 (COVID …

Introduction We have experienced a pandemic induced by the interaction of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins with innate structures …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for
the severe pandemic of acute respiratory disease, coronavirus disease 2019 (COVID-19) …

The global propagation of SARS-CoV-2 leads to an unprecedented public health
emergency. Despite that the lungs are the primary organ targeted by COVID-19, systemic …